Sign In

Eric Lu

PhD Candidate specializing in CRISPR-Cas and anti-CRISPR research - Investor at REMUS Capital

Eric Lu is a research scientist with a strong background in biochemistry and molecular cell biology, boasting over 6 years of experience in the field.

His expertise lies in CRISPR and anti-CRISPR technology, genome engineering, as well as protein and nucleic acid biochemistry.

Eric has demonstrated exceptional skills in both independent and team-oriented work environments, coupled with a successful history of conceptualizing and executing ambitious research ventures.

He holds a Doctor of Philosophy (PhD) in Biochemistry from the University of Toronto and a Bachelor of Science (BS) in Biochemistry from The University of British Columbia.

Throughout his career, Eric has served in various roles such as Campus Associate at REMUS Capital, Campus Analyst - Biotech at Romulus Capital, and as a researcher at esteemed organizations including the Centre for Heart Lung Innovation (HLI), Arbutus Biopharma Corporation, and Sci Pharmtech Inc.

Eric Lu
Add to my network

Location

Toronto, Canada Area